Myelodysplastic-Myeloproliferative Diseases
3 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Sonrotoclax for myelodysplastic-myeloproliferative diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sonrotoclax + Azacitidine for myelodysplastic-myeloproliferative diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Sonrotoclax + Posaconazole + Azacitidine for myelodysplastic-myeloproliferative diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |